MP 17 (Thioridazine 50 mg)
Pill imprint MP 17 has been identified as Thioridazine hydrochloride 50 mg.
Thioridazine is used in the treatment of schizophrenia and belongs to the drug class phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy. Thioridazine 50 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about thioridazine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.